Niloff P H, Sheiner N M
Can J Surg. 1981 Jan;24(1):50, 52.
Because of reports that negative mammographic findings have resulted in a delay of treatment in patients with breast cancer, the authors reviewed their experience with mammography in 160 patients, admitted to the Sir Mortimer B. Davis-Jewish General Hospital in Montreal over a 28-month period, who had histologically verified carcinoma of the breast. Of these patients 153 had clinically palpable masses and 7 had occult carcinomas. The mammogram was considered to be positive for carcinoma in 112 (73.2%) and negative in 41 (26.8%). In 44 patients under the age of 50 years the mammogram was positive in 26 (59.1%) and negative in 18 (40.9%), a significant difference (P less than 0.05). There was no significant difference between the findings of mammograms read by the hospital radiologists and those read by community radiologists. This study confirms the findings of others that mammography is not a reliable technique for evaluating the clinically suspicious breast lesion and must not be used as a substitute for biopsy of such lesions.
由于有报道称乳腺钼靶检查结果为阴性导致乳腺癌患者治疗延迟，作者回顾了他们对160例乳腺癌患者进行钼靶检查的经验。这些患者在28个月的时间里被收治于蒙特利尔市的莫蒂默·B·戴维斯-犹太综合医院，且经组织学证实患有乳腺癌。其中153例患者临床上可触及肿块，7例为隐匿性癌。钼靶检查结果显示，112例（73.2%）为癌阳性，41例（26.8%）为阴性。在44例50岁以下的患者中，钼靶检查阳性26例（59.1%），阴性18例（40.9%），差异有统计学意义（P<0.05）。医院放射科医生和社区放射科医生对钼靶检查结果的判读没有显著差异。本研究证实了其他研究的结果，即钼靶检查并非评估临床上可疑乳腺病变的可靠技术，绝不能用作此类病变活检的替代方法。
